| Topical cannabis‐based medicines–a novel paradigm and treatment for non‐uremic calciphylaxis leg ulcers: an open label trial V Maida, RB Shi, FGT Fazzari, L Zomparelli International wound journal 17 (5), 1508-1516, 2020 | 44 | 2020 |
| Topical cannabis‐based medicines–A novel adjuvant treatment for venous leg ulcers: An open‐label trial V Maida, RB Shi, FGT Fazzari, L Zomparelli Experimental Dermatology 30 (9), 1258-1267, 2021 | 20 | 2021 |
| The current landscape of systemic therapy for recurrent glioblastoma: A systematic review of randomized-controlled trials FGT Fazzari, F Rose, M Pauls, E Guay, MFK Ibrahim, B Basulaiman, M Tu, ... Critical Reviews in Oncology/Hematology 169, 103540, 2022 | 12 | 2022 |
| Molecular biomarkers of response to PD-1/PD-L1 immune checkpoint blockade in advanced bladder cancer MM Tu, TL Ng, FC De Jong, T Zuiverloon, FGT Fazzari, D Theodorescu Bladder Cancer 5 (2), 131-145, 2019 | 9 | 2019 |
| A new treatment paradigm for sickle cell disease leg ulcers: Topical cannabis‐based medicines V Maida, RB Shi, FGT Fazzari, LM Zomparelli Experimental Dermatology 30 (2), 291-293, 2021 | 8 | 2021 |
| Promoting wound healing of uremic calciphylaxis leg ulcers using topical cannabis‐based medicines. V Maida, RB Shi, FGT Fazzari, L Zomparelli Dermatologic Therapy 33 (6), 2020 | 8 | 2020 |
| Combined Targeting of the Glutathione and Thioredoxin Antioxidant Systems in Pancreatic Cancer F Fazzari, S Chow, M Cheung, SH Barghout, AD Schimmer, Q Chang, ... ACS Pharmacology & Translational Science 5 (11), 1070-1078, 2022 | 4 | 2022 |
| Comment on “Cannabinoids in dermatologic surgery” FGT Fazzari, V Maida Journal of the American Academy of Dermatology 85 (6), e409-e410, 2021 | 1 | 2021 |
| Molecular biomarkers of response to PD-1/PD-L1 immune checkpoint blockade in advanced bladder cancer (vol 5, pg 131, 2019) MM Tu, TL Ng, FC De Jong, T Zuiverloon, FGT Fazzari, D Theodorescu Bladder Cancer 6 (4), 559-559, 2020 | 1 | 2020 |
| INNV-31. PROTECT: PROCARBAZINE, LOMUSTINE, AND VINCRISTINE VERSUS TEMOZOLAMIDE IN HIGH-RISK, LOW-GRADE GLIOMAS: A RETROSPECTIVE COHORT STUDY J Jia, B Alshamsan, C Andronic, F Fazzari, J Leigh, H Shah, T Ng Neuro-Oncology 24 (Suppl 7), vii148, 2022 | | 2022 |
| Molecular Biomarkers of Response to PD-1/PD-L1 Immune Checkpoint Blockade in Advanced Bladder Cancer (vol 6, pg 559, 2020) MM Tu, TL Ng, FC De Jong, T Zuiverloon, FGT Fazzari, D Theodorescu BLADDER CANCER 7 (1), 109-109, 2021 | | 2021 |
| Targeting Antioxidant Systems to Treat Pancreatic Cancer FGT Fazzari University of Toronto (Canada), 2018 | | 2018 |
| Article type: Correspondence V Maida, RB Shi, MD BASc, FGT Fazzari, LM Zomparelli | | |
| Molecular Biomarkers of Response to PD-1/PD-L1 Immune Checkpoint Blockade in Advanced Bladder Cancer. MM Tu, TL Ng, FC De Jong, TCM Zuiverloon, FGT Fazzari, ... | | |
